Innopecia 1 mg. FC Tablets,
PDF Leaflet Revision Date: 30 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Temporarily delays hair loss and increases hair density in males with androgenetic alopecia.
Dosage (summary)
1 mg tablet daily, with or without food.
Onset of Action / Duration
Onset: 3 months, Duration: Reversible within 12 months after withdrawal.
Special Populations
- Paediatric population
- Elderly
Pregnancy & Breastfeeding
Contraindicated in women, especially during pregnancy due to risk to male fetus.
Key Drug Interactions
- 5u03b1-reductase inhibitors
- Cytochrome P450 3A4 inducers/inhibitors
Contraindications
- Hypersensitivity
- Women
- Children
Common side effects
- Decreased libido
- Depression
- Breast tenderness
- Impotence
Counselling Points
- Monitor for psychiatric symptoms
- Avoid exposure to pregnant women
- Report breast changes
Serious warnings
- Risk of male infertility
- Mood alterations
- Breast cancer risk
Important Disclaimer
The Innopecia 1 mg. FC Tablets, professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
